Xu Y - Search Results

1

ce-Subpathway: Identification of ceRNA-mediated subpathways via joint power of ceRNAs and pathway topologies.

Feng C, Song C, Ning Z, Ai B, Wang Q, Xu Y, Li M, Bai X, Zhao J, Liu Y, Li X, Zhang J, Li C. Feng C, et al. Among authors: xu y. J Cell Mol Med. 2019 Feb;23(2):967-984. doi: 10.1111/jcmm.13997. Epub 2018 Nov 12. J Cell Mol Med. 2019. PMID: 30421585 Free PMC article.

2

Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways.

Feng C, Zhang J, Li X, Ai B, Han J, Wang Q, Wei T, Xu Y, Li M, Li S, Song C, Li C. Feng C, et al. Among authors: xu y. Sci Rep. 2016 Sep 14;6:33262. doi: 10.1038/srep33262. Sci Rep. 2016. PMID: 27625019 Free PMC article.

3

MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.

Wen J, Xu H, Liu R, Chen Q, Dai Y, Xu Y. Wen J, et al. Among authors: xu h, xu y. Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):24-31. Cell Mol Biol (Noisy-le-grand). 2020. PMID: 32538743

4

Longitudinal Trends in Anxiety, Depression, and Quality of Life During Different Intermittent Periods of Adjuvant Breast Cancer Chemotherapy.

Zhang J, Zhou Y, Feng Z, Xu Y, Zeng G. Zhang J, et al. Among authors: xu y. Cancer Nurs. 2018 Jan/Feb;41(1):62-68. doi: 10.1097/NCC.0000000000000451. Cancer Nurs. 2018. PMID: 27922916

5

Prognostic value of long non-coding RNA HOTAIR in various cancers.

Deng Q, Sun H, He B, Pan Y, Gao T, Chen J, Ying H, Liu X, Wang F, Xu Y, Wang S. Deng Q, et al. Among authors: xu y. PLoS One. 2014 Oct 10;9(10):e110059. doi: 10.1371/journal.pone.0110059. eCollection 2014. PLoS One. 2014. PMID: 25303230 Free PMC article.

6

Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.

Chen D, Chen W, Xu Y, Zhu M, Xiao Y, Shen Y, Zhu S, Cao C, Xu X. Chen D, et al. Among authors: xu x, xu y. J Med Genet. 2019 Jan;56(1):43-49. doi: 10.1136/jmedgenet-2018-105454. Epub 2018 Jul 2. J Med Genet. 2019. PMID: 29967134

7

A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis.

Wu Q, Xu Y, Zhang KJ, Jiang SM, Zhou Y, Zhao Y. Wu Q, et al. Among authors: xu y. Biomed Res Int. 2020 Dec 7;2020:8848919. doi: 10.1155/2020/8848919. eCollection 2020. Biomed Res Int. 2020. PMID: 33376746 Free PMC article.

8

GNAS mutations suppress cell invasion by activating MEG3 in growth hormone-secreting pituitary adenoma.

Tang C, Zhong C, Zhu J, Yuan F, Yang J, Xu Y, Ma C. Tang C, et al. Among authors: xu y. Oncol Res. 2024 May 23;32(6):1079-1091. doi: 10.32604/or.2024.046007. eCollection 2024. Oncol Res. 2024. PMID: 38827318 Free PMC article.

9

[Meta-analysis of Banmao Capsules in adjuvant treatment for non-small cell lung cancer].

Xu Y, Peng WP, Han D, Feng FC, Wang ZC, Gu C, Zhou XM. Xu Y, et al. Zhongguo Zhong Yao Za Zhi. 2020 Aug;45(16):3967-3973. doi: 10.19540/j.cnki.cjcmm.20200115.503. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32893596 Chinese.

10

[Meta-analysis of Cinobufacini Injection combined with platinum-contained first-line chemotherapy in treatment of non-small cell lung cancer].

Xu Y, Han D, Feng FC, Wang ZC, Gu C, Peng WP, He HL, Zhou XM. Xu Y, et al. Zhongguo Zhong Yao Za Zhi. 2019 Nov;44(21):4728-4737. doi: 10.19540/j.cnki.cjcmm.20190505.501. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 31872671 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,157 results

Search Page

Filters